BRCA1 and ovarian carcinoma: This drug is mainly indicated for ovarian cancer, fallopian tube cancer, peritoneal cancer, pancreatic cancer, and prostate cancer with hereditary or somatic BRCA1 or BRCA2 mutation [1, 2].